Discuss National Oilwell Varco
NOV Inc.
WKN: A2QLRE / Symbol: NOV / Name: NOV / Aktie / Öl & Gas - Ausrüstung und Service / Mid Cap /
16,01 €
2,04 %
Buy National Oilwell Varco
Sell NOV Inc.
NOV Inc. (NYSE: NOV) had its price target lowered by analysts at Citigroup Inc. from $25.00 to $23.00. They now have a "buy" rating on the stock.
Ratings data for NOV provided by MarketBeat
NOV Inc. (NYSE: NOV) had its price target lowered by analysts at Raymond James from $29.00 to $27.00. They now have an "outperform" rating on the stock.
Ratings data for NOV provided by MarketBeat
NOV Inc. (NYSE: NOV) had its price target raised by analysts at Raymond James from $27.00 to $28.00. They now have an "outperform" rating on the stock.
Ratings data for NOV provided by MarketBeat
NOV Inc. (NYSE: NOV) had its price target raised by analysts at Morgan Stanley from $22.00 to $24.00. They now have an "overweight" rating on the stock.
Ratings data for NOV provided by MarketBeat
NOV Inc. (NYSE: NOV) was downgraded by analysts at Barclays PLC from an "equal weight" rating to an "underweight" rating. They now have a $20.00 price target on the stock.
Ratings data for NOV provided by MarketBeat
NOV Inc. (NYSE: NOV) had its price target raised by analysts at Morgan Stanley from $24.00 to $25.00. They now have an "overweight" rating on the stock.
Ratings data for NOV provided by MarketBeat
NOV Inc. (NYSE: NOV) had its price target raised by analysts at Raymond James from $28.00 to $29.00. They now have an "outperform" rating on the stock.
Ratings data for NOV provided by MarketBeat
NOV Inc. (NYSE: NOV) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $25.00 price target on the stock, up previously from $22.00.
Ratings data for NOV provided by MarketBeat
NOV Inc. (NYSE: NOV) had its price target raised by analysts at TD Cowen from $28.00 to $29.00. They now have an "outperform" rating on the stock.
Ratings data for NOV provided by MarketBeat
NOV Inc. (NYSE: NOV) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for NOV provided by MarketBeat
NOV Inc. (NYSE: NOV) was given a new $33.00 price target on by analysts at ATB Capital. They now have an "outperform" rating on the stock.
Ratings data for NOV provided by MarketBeat
NOV Inc. (NYSE: NOV) had its price target lowered by analysts at Raymond James from $28.00 to $25.00. They now have an "outperform" rating on the stock.
Ratings data for NOV provided by MarketBeat
NOV Inc. (NYSE: NOV) had its price target lowered by analysts at TD Cowen from $31.00 to $30.00. They now have an "outperform" rating on the stock.
Ratings data for NOV provided by MarketBeat
NOV Inc. (NYSE: NOV) had its price target lowered by analysts at Stifel Nicolaus from $28.00 to $26.00. They now have a "buy" rating on the stock.
Ratings data for NOV provided by MarketBeat
NOV Inc. (NYSE: NOV) had its "positive" rating re-affirmed by analysts at Susquehanna. They now have a $26.00 price target on the stock.
Ratings data for NOV provided by MarketBeat
NOV Inc. (NYSE: NOV) had its price target lowered by analysts at TD Cowen from $27.00 to $26.00. They now have a "buy" rating on the stock.
Ratings data for NOV provided by MarketBeat
NOV Inc. (NYSE: NOV) had its price target lowered by analysts at Bank of America Co. from $24.00 to $22.00. They now have a "buy" rating on the stock.
Ratings data for NOV provided by MarketBeat
NOV Inc. (NYSE: NOV) had its price target raised by analysts at TD Cowen from $27.00 to $28.00. They now have a "buy" rating on the stock.
Ratings data for NOV provided by MarketBeat
Neueste Beiträge
UBS_Group_AG in PTC Therapeutics Inc. diskutieren